A detailed history of Quantbot Technologies LP transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Quantbot Technologies LP holds 10,420 shares of FLGT stock, worth $160,989. This represents 0.01% of its overall portfolio holdings.

Number of Shares
10,420
Previous 4,494 131.86%
Holding current value
$160,989
Previous $97,000 97.94%
% of portfolio
0.01%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025

BUY
$16.71 - $22.68 $99,023 - $134,401
5,926 Added 131.86%
10,420 $192,000
Q3 2024

Nov 13, 2024

SELL
$19.6 - $25.06 $56,016 - $71,621
-2,858 Reduced 38.87%
4,494 $97,000
Q2 2024

Aug 09, 2024

SELL
$19.09 - $22.57 $166,445 - $196,787
-8,719 Reduced 54.25%
7,352 $144,000
Q1 2024

May 06, 2024

BUY
$21.55 - $29.29 $215,650 - $293,105
10,007 Added 165.02%
16,071 $348,000
Q4 2023

Feb 14, 2024

SELL
$23.64 - $30.27 $158,269 - $202,657
-6,695 Reduced 52.47%
6,064 $175,000
Q3 2023

Nov 07, 2023

BUY
$26.74 - $40.81 $295,263 - $450,624
11,042 Added 643.1%
12,759 $341,000
Q2 2023

Aug 08, 2023

BUY
$28.52 - $40.7 $48,968 - $69,881
1,717 New
1,717 $63,000
Q4 2022

Feb 13, 2023

BUY
$29.23 - $40.28 $633,209 - $872,585
21,663 Added 11584.49%
21,850 $650,000
Q3 2022

Nov 07, 2022

BUY
$37.92 - $63.74 $7,091 - $11,919
187 New
187 $7,000
Q3 2021

Nov 09, 2021

SELL
$74.87 - $110.87 $125,107 - $185,263
-1,671 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$66.8 - $100.45 $111,622 - $167,851
1,671 New
1,671 $154,000
Q1 2021

May 14, 2021

SELL
$59.3 - $183.85 $15,892 - $49,271
-268 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$31.01 - $52.1 $8,310 - $13,962
268 New
268 $13,000
Q1 2020

May 13, 2020

SELL
$6.75 - $19.75 $3,375 - $9,875
-500 Closed
0 $0
Q4 2019

Feb 10, 2020

BUY
$9.29 - $15.82 $4,645 - $7,910
500 New
500 $6,000

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $468M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Quantbot Technologies LP Portfolio

Follow Quantbot Technologies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.